A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01)

PHASE3CompletedINTERVENTIONAL
Enrollment

465

Participants

Timeline

Start Date

October 15, 2016

Primary Completion Date

September 21, 2018

Study Completion Date

November 8, 2018

Conditions
Depressive Disorder, Major
Interventions
DRUG

Rapastinel

Rapastinel pre-filled syringes for weekly IV injections.

DRUG

Placebo

Placebo-matching rapastinel pre-filled syringes for weekly IV injections.

Trial Locations (31)

10128

Eastside Comprehensive Medical Center, LLC, New York

10549

Bioscience Research, Mount Kisco

14618

Finger Lakes Clinical Research, Rochester

30005

Institute for Advanced Medical Research, Alpharetta

30331

Atlanta Center for Medical Research, Atlanta

32256

Clinical Neuroscience Solutions, Inc, Jacksonville

33009

MD Clinical, Hallandale

33805

Meridien Research, Lakeland

34201

Meridien Research, Bradenton

38119

Clinical Neuroscience Solutions, Inc, Memphis

44718

Neuro-Behavioral Clinical Research, Inc, Canton

45219

University of Cincinnati, Cincinnati

45417

Midwest Clinical Research Center LLC, Dayton

73103

IPS Research, Oklahoma City

78229

Clinical Trials of Texas, San Antonio

78737

Donald J. Garcia, Jr., MD, PA, Austin

89102

Altea Research, Las Vegas

90036

Southern California Research LLC., Beverly Hills

90720

Pharmacology Research Institute, Los Alamitos

91316

Pharmacology Research Institute, Encino

91403

Thomas M. Shiovitz, M.D., Inc., DBA California Neuroscience Research Medical Group, Inc.,, Sherman Oaks

91786

Pacific Clinical Research Medical, Upland

91945

Synergy San Diego, Lemon Grove

92056

Excell Research, Oceanside

92374

Anderson Clinical Research, Redlands

92591

Viking Clinical Research, Temecula

92626

ATP Clinical Research Inc., Costa Mesa

92845

Collaborative Neuroscience Network, LLC, Garden Grove

98007

NorthWest Clinical Research Center, Bellevue

06360

Comprehensive Psychiatric Care, Norwich

02472

Adams Clinical Trials, Watertown

All Listed Sponsors
lead

Naurex, Inc, an affiliate of Allergan plc

INDUSTRY

NCT02932943 - A Study of Rapastinel as Adjunctive Therapy in Major Depressive Disorder (RAP-MD-01) | Biotech Hunter | Biotech Hunter